DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Poplin E et al.
Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.
Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2009; 3778-3785
We do not assume any responsibility for the contents of the web pages of other providers.